文献速递血栓与止血

凝血酶通过纤维蛋白聚合及血小板-中性粒细胞相互作用促进肺炎源性脓毒症的保护性免疫

Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions.
PubMed 文献 · J Thromb Haemost · 2017-02-16

该研究在小鼠肺炎源性脓毒症模型中,使用达比加群抑制凝血酶或使用安克洛酶去除纤维蛋白原,发现凝血酶抑制会增强细菌生长和播散并加速死亡;凝血酶和纤维蛋白聚合在体外抑制肺炎克雷伯菌生长,且该作用依赖中性粒细胞,凝血酶的作用还需血小板及血小板蛋白酶激活受体-1。

要点

  • 达比加群抑制凝血酶可增强肺炎克雷伯菌生长播散并加速小鼠死亡。
  • 纤维蛋白原去除同样增强细菌生长播散,凝血酶抑制无额外效应。
  • 凝血酶体外抑菌依赖中性粒细胞、血小板及血小板蛋白酶激活受体-1。

核心结论

  • 凝血酶通过纤维蛋白聚合和增强血小板-中性粒细胞相互作用,在肺炎源性脓毒症中发挥重要的保护性免疫作用。

研究设计与样本

  • 小鼠经气道感染人类脓毒症常见病原体肺炎克雷伯菌,分别给予特异性凝血酶抑制剂达比加群或对照饲料。
  • 后续感染实验中,小鼠额外给予安克洛酶以去除纤维蛋白原。
  • 体外将人全血或特定血液成分在不同条件下与肺炎克雷伯菌孵育,评估细菌生长。

主要发现

  • 达比加群抑制凝血酶增强了细菌生长和播散,并加速死亡。
  • 凝血酶抑制未影响中性粒细胞向肺募集、活化或中性粒细胞胞外诱捕网形成。
  • 达比加群减少了D-二聚体形成和肺内纤维蛋白沉积。
  • 去除纤维蛋白原也增强了细菌生长和播散,且凝血酶抑制无额外效应。
  • 凝血酶和纤维蛋白聚合在体外抑制人全血中肺炎克雷伯菌生长,该作用依赖中性粒细胞,凝血酶的作用需血小板及血小板蛋白酶激活受体-1存在。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials Immunity and coagulation are linked during sepsis but the role of thrombin is not fully elucidated. We investigated the effect of thrombin inhibition on murine Klebsiella pneumosepsis outcome. Thrombin is crucial for survival and limiting bacterial growth in pneumonia derived sepsis. Thrombin improves host defense via fibrin and enhancement of platelet-neutrophil interactions. SUMMARY: Background Innate immunity and coagulation are closely linked during sepsis. Their interaction can be detrimental to the outcome because of microvascular failure but can also enhance host defense. The role of thrombin therein has not been fully elucidated. Objective We aimed to investigate the contribution of thrombin to the host response during pneumonia-derived sepsis. Methods Mice treated with the specific thrombin inhibitor dabigatran or control chow were infected with the common human sepsis pathogen Klebsiella (K.) pneumoniae via the airways. In subsequent infection experiments, mice were additionally treated with ancrod to deplete fibrinogen. Ex vivo Klebsiella growth was assessed by incubating human whole blood or specific blood components in various conditions with Klebsiella. Results Thrombin inhibition by dabigatran enhanced bacterial outgrowth and spreading, and accelerated mortality. Thrombin inhibition did not influence neutrophil recruitment to the lung or activation or neutrophil extracellular trap formation. Dabigatran reduced D-dimer formation and fibrin deposition in the lung. Fibrin depletion also enhanced bacterial outgrowth and spreading, and thrombin inhibition had no additional effect. Both thrombin and fibrin polymerization inhibited ex vivo Klebsiella outgrowth in human whole blood, which was neutrophil dependent, and the effect of thrombin required the presence of platelets and platelet protease activated receptor-1. In vivo thrombin inhibition reduced platelet-neutrophil complex formation and endothelial cell activation, but did not prevent sepsis-induced thrombocytopenia or organ damage. Conclusions These results suggest that thrombin plays an important role in protective immunity during pneumonia-derived sepsis by fibrin polymerization and enhancement of platelet-neutrophil interactions.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Claushuis TA, de Stoppelaar SF, Stroo I, et al. Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions. J Thromb Haemost. 2017. PMID: 28092405. doi:10.1111/jth.13625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。